TP53 and cancer: Further studies, with greater and more diverse representativeness of Brazilian population, could provide an optimized strategy for identification of Brazilian HBOC patients at high-risk of carrying PV/LPV in BRCA1/2 and TP53, through a combination of international guidelines, risk prediction models (especially for BRCA1), and familial history of cancer (especially for BRCA2).